Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prolonged Infusion Compared to Standard Infusion Cefepime as Empiric Treatment of Febrile Neutropenia: A Pilot Study

NCT01484015 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT01484015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01484015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prolonged Infusion Compared to Standard Infusion Cefepime as Empiric Treatment of Febrile Neutropenia: A Pilot Study
Lead sponsor
Wake Forest University Health Sciences
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2011
Completion date
October 31, 2012
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult acute lymphoblastic leukemia, adult acute myeloid leukemia, adult burkitt lymphoma, adult diffuse large cell lymphoma, adult diffuse mixed cell lymphoma, adult diffuse small cleaved cell lymphoma, adult hodgkin lymphoma, adult immunoblastic large cell lymphoma, adult lymphoblastic lymphoma, atypical chronic myeloid leukemia, bcr-abl1 negative, breast cancer, chronic eosinophilic leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia, chronic myelomonocytic leukemia, chronic neutrophilic leukemia, cutaneous t-cell non-hodgkin lymphoma, disseminated neuroblastoma, extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue, grade 1 follicular lymphoma, grade 2 follicular lymphoma, grade 3 follicular lymphoma, malignant testicular germ cell tumor, mantle cell lymphoma, marginal zone lymphoma, multiple myeloma, mycosis fungoides/sezary syndrome, myelodysplastic syndromes, myelodysplastic/myeloproliferative neoplasms, neutropenia, nodal marginal zone b-cell lymphoma, ovarian epithelial cancer, ovarian germ cell tumor, plasma cell neoplasm, poor prognosis metastatic gestational trophoblastic tumor, primary myelofibrosis, prolymphocytic leukemia, small lymphocytic lymphoma, splenic marginal zone lymphoma